Abstract:Background Executive dysfunction, particularly impairments in inhibitory control, is a key aspect of attention deficit hyperactivity disorder (ADHD). Methylphenidate (MPH) is the main treatment for ADHD; however, its effects on cortical activation and inhibitory control in children with ADHD have not been comprehensively studied. This study aimed to investigate the differences in functional near-infrared spectroscopy (fNIRS) outcomes related to inhibitory control improvement and cortical activation in children with ADHD. Methods Between May 2023 and December 2023, 14 children diagnosed with ADHD and treated with MPH were recruited, and 17 healthy children matched for age and sex were included. fNIRS was used to monitor brain activation in healthy children and children with ADHD before and after medication during Go/Nogo, Stroop, and flanker tasks. Differences in brain activation between healthy children and children with ADHD were compared before and after treatment. Results Swanson, Nolan, and Pelham IV rating scale revealed statistically significant improvements in inattention and hyperactivity-impulsivity in children with ADHD (P < 0.05). Behavior Rating Inventory of Executive Function Parent Edition revealed statistically significant improvements in working memory and monitoring ability after MPH treatment in children with ADHD (P < 0.05). After MPH treatment, the anterior cingulate cortex of the Stroop task significantly improved in children with ADHD (P < 0.05). The fNIRS activation levels in channels 9, 12, 21, and 42 were higher than those in healthy children during the go/no-go task before ADHD medication (P < 0.05). Before medication administration, no significant difference was observed in fNIRS activation between children with ADHD and healthy children during the Stroop and Flanker tasks (P > 0.05). When performing the Go/No-go task, the activation level of channel 7 fNIRS in children with ADHD was lower after treatment than before (P < 0.05). In the Stroop and flaker tasks, no significant differences were observed in fNIRS activation levels in children with ADHD before and after medication (P > 0.05). Conclusions After 8 weeks of treatment with methylphenidate, the behavioral data of children with ADHD showed improvement in the inhibition control neuropsychological test. The characteristic brain regions improved significantly when performing inhibitory control tasks and developed towards the activation direction of healthy children's brain regions.

Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children with Attention-Deficit/Hyperactive Disorder

Effect of Atomoxetine on the Cognitive Functions in Treatment of Attention Deficit Hyperactivity Disorder in Children with Congenital Hypothyroidism: A Pilot Study.

Effects of Extended-released Methylphenidate on the Inhibition of Children with Attention Deficit Hyperactivity Disorder

Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD

Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents

Verbal Working Memory-Related Functional Connectivity Alterations in Boys with Attention-Deficit/hyperactivity Disorder and the Effects of Methylphenidate.

Methylphenidate Normalizes Resting-State Brain Dysfunction in Boys With Attention Deficit Hyperactivity Disorder

Functional Near-Infrared Spectroscopy Study on Inhibitory Control Ability of Children with Attention Deficit Hyperactivity Disorder with Methylphenidate Therapy: an Experimental, Longitudinal, and Neuroimaging Study

The Association with Quantitative Response to Attention-Deficit/Hyperactivity Disorder Medication of the Previously Identified Neurodevelopmental Network Genes.

The Promoting Effects of Digital Targeted Cognitive Training in Medication Treatment for Children with ADHD: A Randomized Controlled Trial

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder

Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study

Improvements of attention deficit/hyperactivity disorder core symptoms and executive function after methylphenidate treatment

Efficacy and Factors of Methylphenidate on Children with Different Subtypes of Attention Deficit Hyperactivity Disorder

The efficacy of atomoxetine in treatment of attention-deficit hyperactivity disorder(ADHD)—Meta-analysis of RCT

Comparative Study Of Oros-Mph And Atomoxetine On Executive Function Improvement In Adhd: A Randomized Controlled Trial

Methylphenidate normalizes aberrant beta oscillations and reduces alpha power during retention in children with ADHD

Functional Mri in Attention-Deficit Hyperactivity Disorder: Evidence for Hypofrontality

The Effects of First-Dose Methylphenidate on the Neural Signatures of Visual Selective Attention in Children with Attention-Deficit/hyperactivity Disorder

Effects of cognitive function in children with attention deficit hyperactivity disorder by drugs combined psychological treatment

[Changes of the Alpha Competitive Structure after Administration of Single Dose Methylphenidate in Different Subtypes of Attention Deficit Hyperactivity Disorder Boys].